Canada's Dentalcorp Q2 revenue rises 8.9% but misses estimates

Overview

• Dentalcorp Q2 revenue rises 8.9% yr/yr but missed analyst expectations

• Adjusted EBITDA for Q2 grows 9.9% yr/yr, margin expands to 18.7%

• Company acquired 8 new practices, expanding footprint to 575 locations

Outlook

• Dentalcorp expects Q3 2025 revenue to grow 10% to 12%

• Company anticipates Q3 2025 SPRG to increase 3% to 5%

• Dentalcorp sees Q3 2025 Adjusted EBITDA Margin at 18.6%

• Company exceeds 2025 acquisition target of C$25 mln PF Adjusted EBITDA after rent

Result Drivers

• PRACTICE ACQUISITIONS - Co acquired 8 new practices, contributing to revenue growth and expanding footprint to 575 locations

• PATIENT VISITS - Achieved 91.8% recurring patient visit rate, indicating stable demand across network

• CDCP IMPACT - Visit deferrals due to Canadian Dental Care Plan affected same practice revenue growth

Key Details

Analyst Coverage

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 11 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

• The average consensus recommendation for the healthcare facilities & services peer group is "buy"

• Wall Street's median 12-month price target for dentalcorp Holdings Ltd is C$12.50, about 34.6% above its August 7 closing price of C$8.17

• The stock recently traded at 15 times the next 12-month earnings vs. a P/E of 17 three months ago

Press Release: ID:nBw9D4lZLa